Does USTEKINUMAB Cause Prostate cancer? 221 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Prostate cancer have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.3% of all adverse event reports for USTEKINUMAB.
221
Reports of Prostate cancer with USTEKINUMAB
0.3%
of all USTEKINUMAB reports
4
Deaths
34
Hospitalizations
How Dangerous Is Prostate cancer From USTEKINUMAB?
Of the 221 reports, 4 (1.8%) resulted in death, 34 (15.4%) required hospitalization, and 8 (3.6%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 221 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
Which USTEKINUMAB Alternatives Have Lower Prostate cancer Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE